Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Hypertrophy, Right Ventricular

resveratrol has been researched along with Hypertrophy, Right Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calvert, AE; Chen, B; Chicoine, LG; Meng, X; Slutzky, JL; Xue, J1
Gao, YH; Hao, XQ; Li, XH; Xu, YL; Yang, DL; Yang, XJ; Zhang, HG1

Other Studies

2 other study(ies) available for resveratrol and Hypertrophy, Right Ventricular

ArticleYear
Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Aug-15, Volume: 307, Issue:4

    Topics: Animals; Arginase; Cell Proliferation; Cells, Cultured; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Myocytes, Smooth Muscle; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Stilbenes

2014
Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:2

    Topics: Animals; Apoptosis; Cardiotonic Agents; Heart; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardium; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2010